Home › Bids
› Preclinical Proof of Concept Studies for Rare Diseases (R21
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Open48 days leftHealthcaregrant
Dec 6, 2024
Jun 2, 2026 12:00 AM
Healthcare
grant
...
AI Summary
This grant opportunity (RFA-TR-25-002) from the NIH funds preclinical proof of concept studies for rare diseases. Clinical trials are not allowed under this R21 mechanism.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.